Cellular Oncology
Overview
Cellular Oncology (Dordrecht) is a peer-reviewed journal that focuses on the molecular and cellular aspects of cancer research. It publishes original articles, reviews, and commentaries, covering topics such as tumor biology, cancer genetics, molecular diagnostics, and targeted therapies. The journal aims to provide a platform for researchers and clinicians to share their findings and advancements in understanding and treating cancer at the cellular level.
Details
Details
Abbr.
Cell Oncol (Dordr)
Publisher
Springer
Start
2011
End
Continuing
Frequency
Bimonthly
p-ISSN
2211-3428
e-ISSN
2211-3436
Country
Netherlands
Language
English
Metrics
Metrics
h-index / Ranks: 6339
58
SJR / Ranks: 1984
1489
CiteScore / Ranks: 1313
10.40
JIF / Ranks: 945
6.6
Recent Articles
1.
Tang Z, Pei K, Xu H, Zheng Y, Zhuang S, Weng K, et al.
Cell Oncol (Dordr)
. 2025 Mar;
PMID: 40035982
Introduction: Germline CDKN2A variant predisposes to childhood acute lymphoblastic leukemia (ALL) through allelic expression imbalance (AEI). It is unknown, therefore, how these germline variations work and whether they all confer...
2.
Elfving H, Yu H, Fessehatsion K, Brunnstrom H, Botling J, Gulyas M, et al.
Cell Oncol (Dordr)
. 2025 Mar;
PMID: 40029549
Introduction: Tertiary lymphoid structures (TLS) are lymphocyte aggregates resembling secondary lymphoid organs and are pivotal in cancer immunity. The ambiguous morphological definition of TLS makes it challenging to ascertain their...
3.
Wang J, Xu X, Wang Y, Zhu Y
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 40009128
Purpose: Immune checkpoint plus tyrosine kinase inhibition (IO + TKI) has emerged as the first-line therapy in metastatic renal cell carcinoma (RCC), but no biomarker can predict its efficacy. Thymidine...
4.
Toghraie F, Bayat M, Hosseini M, Ramezani A
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39998754
Tumor-infiltrating myeloid cells (TIMs), which encompass tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), myeloid-derived suppressor cells (MDSCs), and tumor-associated dendritic cells (TADCs), are of great importance in tumor microenvironment (TME) and...
5.
Tusa I, Gagliardi S, Menconi A, Maresca L, Tubita A, Lulli M, et al.
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39998753
Purpose: Malignant melanoma is the deadliest skin cancer, with a poor prognosis in advanced stages. We reported that both Hedgehog-GLI (HH/GLI) and Mitogen-activated protein Kinase (MAPK) extracellular signal-regulated kinase 5...
6.
Liu Y, Ding J, Li S, Jiang A, Chen Z, Quan M
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39962015
No abstract available.
7.
Das S, Nayak A, Siddharth S, Nayak D, Narayan S, Kundu C
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39962014
No abstract available.
8.
Yu J, Yao R, Han N, Lu L, Chen L, Reyila A, et al.
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39962013
Purpose: To propose a new optimal strategy for incorporating tumor deposit (TD) into TNM staging. Methods: Totally, 2730 consecutive gastric cancer (GC) patients were included according to the presence and...
9.
Ortiz-Sanchez P, Gonzalez-Soto S, Villamizar L, Valencia J, Jimenez E, Sacedon R, et al.
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39937211
Purpose: Central nervous system (CNS) involvement and/or relapse remains one of the most important causes of morbidity/mortality in paediatric B-cell precursor acute lymphoblastic leukaemia (BCP-ALL) patients. To identify novel therapeutic...
10.
Capik O, Karatas O
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39928285
Hypoxia is a critical microenvironmental condition that plays a major role in driving tumorigenesis and cancer progression. Increasing evidence has revealed novel functions of hypoxia in intercellular communication. The hypoxia...